CBH Profitability Analysis: Margins, Return on Capital, Free Cash Flow, and More - Coloplast A/S

Watchlist Manager

Watchlist

Price: 6.25 EUR

Market Cap: €14.1B

C	Coloplast A/S F:CBH	DK
	Renaissancere Holdings Ltd F:RRJ	BM
I	Iovance Biotherapeutics Inc F:2LB	US
S	Schneider Electric SE F:SND	FR
	Ulker Biskuvi Sanayi AS F:A7G	TR
H	Home Product Center PCL SET:HMPRO	TH
U	United Therapeutics Corp XMUN:UTH	US
	CI Banco SA Institucion de Banca Multiple FF/00939 OTC:CBAOF	MX

Profitability Summary

Coloplast A/S's profitability score is Hidden . We take all the information about a company's profitability, such as its margins, capital efficiency, free cash flow generating ability, and more, and consolidate it into one single number: the profitability score. The higher the profitability score, the more profitable the company is.

Exceptional Gross Margin

67%

Strong 3Y Average Gross Margin

67%

Gross Margin is Increasing

67% > 67%

Healthy Operating Margin

27%

Sustainable 3Y Average Operating Margin

27%

Declining Operating Margin

28% > 27%

Low Net Margin

10%

Sustainable 3Y Average Net Margin

15%

Declining Net Margin

20% > 10%

Exceptional Free Cash Flow Margin

22%

Strong 3Y Average Free Cash Flow Margin

14%

Free Cash Flow Margin is Increasing

12% > 22%

Positive ROE

19%

Exceptional 3Y Average ROE

Positive 3Y Average ROIC

12%

Declining ROIC

14% > 12%

View All Checks

We take all the information about a company's profitability, such as its margins, capital efficiency, free cash flow generating ability, and more, and consolidate it into one single number: the profitability score. The higher the profitability score, the more profitable the company is.